nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—SCN4A—epilepsy syndrome	0.341	1	CbGaD
Levobupivacaine—SCN4A—Lamotrigine—epilepsy syndrome	0.0488	0.107	CbGbCtD
Levobupivacaine—SCN10A—Lacosamide—epilepsy syndrome	0.0453	0.0991	CbGbCtD
Levobupivacaine—SCN10A—Lamotrigine—epilepsy syndrome	0.0453	0.0991	CbGbCtD
Levobupivacaine—SCN4A—Rufinamide—epilepsy syndrome	0.0431	0.0941	CbGbCtD
Levobupivacaine—SCN4A—Carbamazepine—epilepsy syndrome	0.042	0.0917	CbGbCtD
Levobupivacaine—SCN10A—Rufinamide—epilepsy syndrome	0.0401	0.0875	CbGbCtD
Levobupivacaine—SCN4A—Phenytoin—epilepsy syndrome	0.0377	0.0823	CbGbCtD
Levobupivacaine—SCN4A—Propofol—epilepsy syndrome	0.0351	0.0767	CbGbCtD
Levobupivacaine—SCN4A—Zonisamide—epilepsy syndrome	0.0311	0.0679	CbGbCtD
Levobupivacaine—CYP1A2—Carbamazepine—epilepsy syndrome	0.00619	0.0135	CbGbCtD
Levobupivacaine—CYP1A2—Primidone—epilepsy syndrome	0.00578	0.0126	CbGbCtD
Levobupivacaine—CYP1A2—Propofol—epilepsy syndrome	0.00517	0.0113	CbGbCtD
Levobupivacaine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00516	0.0113	CbGbCtD
Levobupivacaine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00495	0.0108	CbGbCtD
Levobupivacaine—CYP3A4—Felbamate—epilepsy syndrome	0.0048	0.0105	CbGbCtD
Levobupivacaine—CYP3A4—Trimethadione—epilepsy syndrome	0.0048	0.0105	CbGbCtD
Levobupivacaine—CYP1A2—Diazepam—epilepsy syndrome	0.00469	0.0102	CbGbCtD
Levobupivacaine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00451	0.00986	CbGbCtD
Levobupivacaine—CYP3A4—Clonazepam—epilepsy syndrome	0.00408	0.00892	CbGbCtD
Levobupivacaine—CYP3A4—Clobazam—epilepsy syndrome	0.00391	0.00855	CbGbCtD
Levobupivacaine—CYP1A2—Valproic Acid—epilepsy syndrome	0.0037	0.00808	CbGbCtD
Levobupivacaine—CYP3A4—Rufinamide—epilepsy syndrome	0.00333	0.00727	CbGbCtD
Levobupivacaine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00324	0.00708	CbGbCtD
Levobupivacaine—CYP3A4—Primidone—epilepsy syndrome	0.00303	0.00661	CbGbCtD
Levobupivacaine—CYP3A4—Phenytoin—epilepsy syndrome	0.00291	0.00635	CbGbCtD
Levobupivacaine—CYP3A4—Propofol—epilepsy syndrome	0.00271	0.00593	CbGbCtD
Levobupivacaine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00259	0.00566	CbGbCtD
Levobupivacaine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00259	0.00566	CbGbCtD
Levobupivacaine—CYP3A4—Midazolam—epilepsy syndrome	0.00255	0.00558	CbGbCtD
Levobupivacaine—CYP3A4—Diazepam—epilepsy syndrome	0.00246	0.00537	CbGbCtD
Levobupivacaine—CYP3A4—Zonisamide—epilepsy syndrome	0.0024	0.00524	CbGbCtD
Levobupivacaine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00194	0.00423	CbGbCtD
Levobupivacaine—CYP3A4—Topiramate—epilepsy syndrome	0.00175	0.00382	CbGbCtD
Levobupivacaine—Mepivacaine—SCN8A—epilepsy syndrome	0.000326	0.0672	CrCbGaD
Levobupivacaine—Mepivacaine—SCN9A—epilepsy syndrome	0.000264	0.0544	CrCbGaD
Levobupivacaine—Ranolazine—SCN9A—epilepsy syndrome	0.000264	0.0544	CrCbGaD
Levobupivacaine—Ropivacaine—SCN8A—epilepsy syndrome	0.000258	0.0531	CrCbGaD
Levobupivacaine—Mepivacaine—SCN3A—epilepsy syndrome	0.000252	0.052	CrCbGaD
Levobupivacaine—Mepivacaine—SCN4A—epilepsy syndrome	0.000242	0.05	CrCbGaD
Levobupivacaine—Tocainide—SCN8A—epilepsy syndrome	0.000242	0.05	CrCbGaD
Levobupivacaine—Bupivacaine—SCN4A—epilepsy syndrome	0.000237	0.049	CrCbGaD
Levobupivacaine—Ropivacaine—SCN9A—epilepsy syndrome	0.000208	0.043	CrCbGaD
Levobupivacaine—Ropivacaine—SCN3A—epilepsy syndrome	0.000199	0.0411	CrCbGaD
Levobupivacaine—Tocainide—SCN9A—epilepsy syndrome	0.000196	0.0404	CrCbGaD
Levobupivacaine—Ropivacaine—SCN4A—epilepsy syndrome	0.000191	0.0395	CrCbGaD
Levobupivacaine—Tocainide—SCN3A—epilepsy syndrome	0.000187	0.0386	CrCbGaD
Levobupivacaine—Tocainide—SCN4A—epilepsy syndrome	0.00018	0.0371	CrCbGaD
Levobupivacaine—Mepivacaine—SCN1A—epilepsy syndrome	0.000177	0.0365	CrCbGaD
Levobupivacaine—Mepivacaine—SCN2A—epilepsy syndrome	0.000156	0.0322	CrCbGaD
Levobupivacaine—Lidocaine—SCN9A—epilepsy syndrome	0.000151	0.0312	CrCbGaD
Levobupivacaine—Lidocaine—SCN3A—epilepsy syndrome	0.000145	0.0299	CrCbGaD
Levobupivacaine—Ropivacaine—SCN1A—epilepsy syndrome	0.00014	0.0289	CrCbGaD
Levobupivacaine—Lidocaine—SCN4A—epilepsy syndrome	0.000139	0.0287	CrCbGaD
Levobupivacaine—Tocainide—SCN1A—epilepsy syndrome	0.000132	0.0271	CrCbGaD
Levobupivacaine—Ropivacaine—SCN2A—epilepsy syndrome	0.000123	0.0254	CrCbGaD
Levobupivacaine—Tocainide—SCN2A—epilepsy syndrome	0.000116	0.0239	CrCbGaD
Levobupivacaine—Lidocaine—SCN2A—epilepsy syndrome	8.96e-05	0.0185	CrCbGaD
Levobupivacaine—SCN10A—Developmental Biology—PRNP—epilepsy syndrome	5.59e-05	0.00101	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—CDH2—epilepsy syndrome	5.45e-05	0.000988	CbGpPWpGaD
Levobupivacaine—Bupivacaine—CYP2C19—epilepsy syndrome	5.45e-05	0.0112	CrCbGaD
Levobupivacaine—SCN4A—L1CAM interactions—SRC—epilepsy syndrome	5.43e-05	0.000985	CbGpPWpGaD
Levobupivacaine—CYP1A2—Estrogen Receptor Pathway—JUN—epilepsy syndrome	5.36e-05	0.000972	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—ADAM10—epilepsy syndrome	5.3e-05	0.00096	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—CDH2—epilepsy syndrome	5.26e-05	0.000953	CbGpPWpGaD
Levobupivacaine—SCN10A—L1CAM interactions—SRC—epilepsy syndrome	5.24e-05	0.000949	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—ADAM10—epilepsy syndrome	5.11e-05	0.000925	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—ACTB—epilepsy syndrome	5.11e-05	0.000925	CbGpPWpGaD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	5.04e-05	0.000913	CbGpPWpGaD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	5.03e-05	0.000911	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—ITGA2—epilepsy syndrome	5.02e-05	0.000909	CbGpPWpGaD
Levobupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	4.99e-05	0.000905	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—epilepsy syndrome	4.97e-05	0.000901	CbGpPWpGaD
Levobupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	4.96e-05	0.000899	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	4.96e-05	0.000899	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—CDC42—epilepsy syndrome	4.95e-05	0.000897	CbGpPWpGaD
Levobupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	4.93e-05	0.000893	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—ACTB—epilepsy syndrome	4.92e-05	0.000892	CbGpPWpGaD
Levobupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	4.9e-05	0.000887	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—ITGA2—epilepsy syndrome	4.84e-05	0.000876	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—CDC42—epilepsy syndrome	4.77e-05	0.000865	CbGpPWpGaD
Levobupivacaine—CYP1A2—Melatonin metabolism and effects—APOE—epilepsy syndrome	4.57e-05	0.000828	CbGpPWpGaD
Levobupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	4.48e-05	0.000812	CbGpPWpGaD
Levobupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	4.42e-05	0.000801	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—FYN—epilepsy syndrome	4.4e-05	0.000798	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—DLG4—epilepsy syndrome	4.29e-05	0.000777	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—FYN—epilepsy syndrome	4.25e-05	0.00077	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—GRIN2B—epilepsy syndrome	4.19e-05	0.00076	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—DLG4—epilepsy syndrome	4.14e-05	0.00075	CbGpPWpGaD
Levobupivacaine—Ranolazine—CYP2D6—epilepsy syndrome	4.12e-05	0.0085	CrCbGaD
Levobupivacaine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	4.08e-05	0.000739	CbGpPWpGaD
Levobupivacaine—CYP1A2—Tryptophan metabolism—CAT—epilepsy syndrome	4.07e-05	0.000737	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	4.05e-05	0.000733	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—GRIN2B—epilepsy syndrome	4.04e-05	0.000733	CbGpPWpGaD
Levobupivacaine—Bupivacaine—CYP2D6—epilepsy syndrome	4.04e-05	0.00834	CrCbGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	4.02e-05	0.000729	CbGpPWpGaD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	3.89e-05	0.000704	CbGpPWpGaD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	3.88e-05	0.000703	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—AKT3—epilepsy syndrome	3.87e-05	0.000701	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—epilepsy syndrome	3.86e-05	0.0007	CbGpPWpGaD
Levobupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	3.85e-05	0.000698	CbGpPWpGaD
Levobupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	3.83e-05	0.000694	CbGpPWpGaD
Levobupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	3.8e-05	0.000689	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—ADAM10—epilepsy syndrome	3.78e-05	0.000685	CbGpPWpGaD
Levobupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	3.78e-05	0.000685	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—AKT3—epilepsy syndrome	3.73e-05	0.000676	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—ADAM10—epilepsy syndrome	3.64e-05	0.00066	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	3.63e-05	0.000658	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—KDR—epilepsy syndrome	3.63e-05	0.000658	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—CDC42—epilepsy syndrome	3.53e-05	0.00064	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—KDR—epilepsy syndrome	3.5e-05	0.000634	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—IL6ST—epilepsy syndrome	3.48e-05	0.000631	CbGpPWpGaD
Levobupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	3.46e-05	0.000626	CbGpPWpGaD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—GPX1—epilepsy syndrome	3.44e-05	0.000623	CbGpPWpGaD
Levobupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	3.41e-05	0.000618	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—CDC42—epilepsy syndrome	3.4e-05	0.000617	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—IL6ST—epilepsy syndrome	3.36e-05	0.000608	CbGpPWpGaD
Levobupivacaine—Ropivacaine—CYP2D6—epilepsy syndrome	3.26e-05	0.00672	CrCbGaD
Levobupivacaine—SCN4A—Developmental Biology—HES1—epilepsy syndrome	3.23e-05	0.000586	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—FYN—epilepsy syndrome	3.14e-05	0.00057	CbGpPWpGaD
Levobupivacaine—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	3.14e-05	0.000569	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—MEF2C—epilepsy syndrome	3.13e-05	0.000566	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	3.12e-05	0.000566	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—HES1—epilepsy syndrome	3.12e-05	0.000565	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	3.1e-05	0.000563	CbGpPWpGaD
Levobupivacaine—Pruritus—Zonisamide—epilepsy syndrome	3.06e-05	0.000217	CcSEcCtD
Levobupivacaine—Hypersensitivity—Phenytoin—epilepsy syndrome	3.05e-05	0.000216	CcSEcCtD
Levobupivacaine—Flatulence—Gabapentin—epilepsy syndrome	3.04e-05	0.000215	CcSEcCtD
Levobupivacaine—Oedema—Valproic Acid—epilepsy syndrome	3.04e-05	0.000215	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	3.04e-05	0.000215	CcSEcCtD
Levobupivacaine—Urticaria—Lamotrigine—epilepsy syndrome	3.03e-05	0.000215	CcSEcCtD
Levobupivacaine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	3.03e-05	0.000215	CcSEcCtD
Levobupivacaine—Bradycardia—Topiramate—epilepsy syndrome	3.03e-05	0.000215	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—FYN—epilepsy syndrome	3.03e-05	0.000549	CbGpPWpGaD
Levobupivacaine—Nausea—Propofol—epilepsy syndrome	3.03e-05	0.000215	CcSEcCtD
Levobupivacaine—Tension—Gabapentin—epilepsy syndrome	3.03e-05	0.000214	CcSEcCtD
Levobupivacaine—Vomiting—Fosphenytoin—epilepsy syndrome	3.02e-05	0.000214	CcSEcCtD
Levobupivacaine—Diarrhoea—Felbamate—epilepsy syndrome	3.02e-05	0.000214	CcSEcCtD
Levobupivacaine—Body temperature increased—Lamotrigine—epilepsy syndrome	3.02e-05	0.000214	CcSEcCtD
Levobupivacaine—Abdominal pain—Lamotrigine—epilepsy syndrome	3.02e-05	0.000214	CcSEcCtD
Levobupivacaine—Dizziness—Diazepam—epilepsy syndrome	3.02e-05	0.000214	CcSEcCtD
Levobupivacaine—Infection—Valproic Acid—epilepsy syndrome	3.02e-05	0.000214	CcSEcCtD
Levobupivacaine—Syncope—Pregabalin—epilepsy syndrome	3.02e-05	0.000214	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—MEF2C—epilepsy syndrome	3.01e-05	0.000546	CbGpPWpGaD
Levobupivacaine—Nervousness—Gabapentin—epilepsy syndrome	2.99e-05	0.000212	CcSEcCtD
Levobupivacaine—Asthenia—Clonazepam—epilepsy syndrome	2.99e-05	0.000212	CcSEcCtD
Levobupivacaine—Back pain—Gabapentin—epilepsy syndrome	2.98e-05	0.000211	CcSEcCtD
Levobupivacaine—Headache—Fosphenytoin—epilepsy syndrome	2.98e-05	0.000211	CcSEcCtD
Levobupivacaine—Nervous system disorder—Valproic Acid—epilepsy syndrome	2.98e-05	0.000211	CcSEcCtD
Levobupivacaine—Palpitations—Pregabalin—epilepsy syndrome	2.97e-05	0.000211	CcSEcCtD
Levobupivacaine—Asthenia—Phenytoin—epilepsy syndrome	2.97e-05	0.00021	CcSEcCtD
Levobupivacaine—Nausea—Midazolam—epilepsy syndrome	2.96e-05	0.00021	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Topiramate—epilepsy syndrome	2.96e-05	0.00021	CcSEcCtD
Levobupivacaine—Muscle spasms—Gabapentin—epilepsy syndrome	2.96e-05	0.00021	CcSEcCtD
Levobupivacaine—Tachycardia—Valproic Acid—epilepsy syndrome	2.96e-05	0.00021	CcSEcCtD
Levobupivacaine—Diarrhoea—Zonisamide—epilepsy syndrome	2.96e-05	0.00021	CcSEcCtD
Levobupivacaine—Loss of consciousness—Pregabalin—epilepsy syndrome	2.96e-05	0.000209	CcSEcCtD
Levobupivacaine—Asthenia—Oxcarbazepine—epilepsy syndrome	2.95e-05	0.000209	CcSEcCtD
Levobupivacaine—Pruritus—Clonazepam—epilepsy syndrome	2.95e-05	0.000209	CcSEcCtD
Levobupivacaine—Vomiting—Vigabatrin—epilepsy syndrome	2.95e-05	0.000209	CcSEcCtD
Levobupivacaine—Skin disorder—Valproic Acid—epilepsy syndrome	2.95e-05	0.000209	CcSEcCtD
Levobupivacaine—Oedema peripheral—Topiramate—epilepsy syndrome	2.94e-05	0.000208	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	2.93e-05	0.000208	CcSEcCtD
Levobupivacaine—Cough—Pregabalin—epilepsy syndrome	2.93e-05	0.000208	CcSEcCtD
Levobupivacaine—Pruritus—Phenytoin—epilepsy syndrome	2.93e-05	0.000208	CcSEcCtD
Levobupivacaine—Nausea—Levetiracetam—epilepsy syndrome	2.93e-05	0.000207	CcSEcCtD
Levobupivacaine—Dizziness—Felbamate—epilepsy syndrome	2.92e-05	0.000207	CcSEcCtD
Levobupivacaine—Pruritus—Oxcarbazepine—epilepsy syndrome	2.91e-05	0.000206	CcSEcCtD
Levobupivacaine—Convulsion—Pregabalin—epilepsy syndrome	2.91e-05	0.000206	CcSEcCtD
Levobupivacaine—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.91e-05	0.000206	CcSEcCtD
Levobupivacaine—Vision blurred—Gabapentin—epilepsy syndrome	2.91e-05	0.000206	CcSEcCtD
Levobupivacaine—Headache—Vigabatrin—epilepsy syndrome	2.9e-05	0.000206	CcSEcCtD
Levobupivacaine—Hypertension—Pregabalin—epilepsy syndrome	2.9e-05	0.000206	CcSEcCtD
Levobupivacaine—Vomiting—Diazepam—epilepsy syndrome	2.9e-05	0.000206	CcSEcCtD
Levobupivacaine—Tremor—Gabapentin—epilepsy syndrome	2.89e-05	0.000205	CcSEcCtD
Levobupivacaine—Arthralgia—Pregabalin—epilepsy syndrome	2.86e-05	0.000203	CcSEcCtD
Levobupivacaine—Dizziness—Zonisamide—epilepsy syndrome	2.86e-05	0.000203	CcSEcCtD
Levobupivacaine—Headache—Diazepam—epilepsy syndrome	2.86e-05	0.000203	CcSEcCtD
Levobupivacaine—Anxiety—Pregabalin—epilepsy syndrome	2.85e-05	0.000202	CcSEcCtD
Levobupivacaine—Diarrhoea—Clonazepam—epilepsy syndrome	2.85e-05	0.000202	CcSEcCtD
Levobupivacaine—Anaemia—Gabapentin—epilepsy syndrome	2.85e-05	0.000202	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.84e-05	0.000201	CcSEcCtD
Levobupivacaine—Hypotension—Valproic Acid—epilepsy syndrome	2.84e-05	0.000201	CcSEcCtD
Levobupivacaine—Asthenia—Carbamazepine—epilepsy syndrome	2.84e-05	0.000201	CcSEcCtD
Levobupivacaine—Agitation—Gabapentin—epilepsy syndrome	2.83e-05	0.000201	CcSEcCtD
Levobupivacaine—Diarrhoea—Phenytoin—epilepsy syndrome	2.83e-05	0.000201	CcSEcCtD
Levobupivacaine—Nausea—Fosphenytoin—epilepsy syndrome	2.83e-05	0.0002	CcSEcCtD
Levobupivacaine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.82e-05	0.0002	CcSEcCtD
Levobupivacaine—Angioedema—Gabapentin—epilepsy syndrome	2.82e-05	0.0002	CcSEcCtD
Levobupivacaine—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.81e-05	0.000199	CcSEcCtD
Levobupivacaine—Vomiting—Felbamate—epilepsy syndrome	2.81e-05	0.000199	CcSEcCtD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	2.8e-05	0.000508	CbGpPWpGaD
Levobupivacaine—Pruritus—Carbamazepine—epilepsy syndrome	2.8e-05	0.000198	CcSEcCtD
Levobupivacaine—Tinnitus—Topiramate—epilepsy syndrome	2.78e-05	0.000197	CcSEcCtD
Levobupivacaine—Headache—Felbamate—epilepsy syndrome	2.77e-05	0.000196	CcSEcCtD
Levobupivacaine—Confusional state—Pregabalin—epilepsy syndrome	2.77e-05	0.000196	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.77e-05	0.000196	CcSEcCtD
Levobupivacaine—Flushing—Topiramate—epilepsy syndrome	2.77e-05	0.000196	CcSEcCtD
Levobupivacaine—Cardiac disorder—Topiramate—epilepsy syndrome	2.77e-05	0.000196	CcSEcCtD
Levobupivacaine—Syncope—Gabapentin—epilepsy syndrome	2.76e-05	0.000196	CcSEcCtD
Levobupivacaine—Dizziness—Clonazepam—epilepsy syndrome	2.76e-05	0.000195	CcSEcCtD
Levobupivacaine—Nausea—Vigabatrin—epilepsy syndrome	2.75e-05	0.000195	CcSEcCtD
Levobupivacaine—Vomiting—Zonisamide—epilepsy syndrome	2.75e-05	0.000195	CcSEcCtD
Levobupivacaine—Insomnia—Valproic Acid—epilepsy syndrome	2.75e-05	0.000194	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.74e-05	0.000194	CcSEcCtD
Levobupivacaine—Oedema—Pregabalin—epilepsy syndrome	2.74e-05	0.000194	CcSEcCtD
Levobupivacaine—Asthenia—Lamotrigine—epilepsy syndrome	2.74e-05	0.000194	CcSEcCtD
Levobupivacaine—Dizziness—Phenytoin—epilepsy syndrome	2.74e-05	0.000194	CcSEcCtD
Levobupivacaine—Infection—Pregabalin—epilepsy syndrome	2.73e-05	0.000193	CcSEcCtD
Levobupivacaine—Paraesthesia—Valproic Acid—epilepsy syndrome	2.73e-05	0.000193	CcSEcCtD
Levobupivacaine—Palpitations—Gabapentin—epilepsy syndrome	2.72e-05	0.000193	CcSEcCtD
Levobupivacaine—Dizziness—Oxcarbazepine—epilepsy syndrome	2.72e-05	0.000193	CcSEcCtD
Levobupivacaine—Nausea—Diazepam—epilepsy syndrome	2.71e-05	0.000192	CcSEcCtD
Levobupivacaine—Loss of consciousness—Gabapentin—epilepsy syndrome	2.71e-05	0.000192	CcSEcCtD
Levobupivacaine—Headache—Zonisamide—epilepsy syndrome	2.71e-05	0.000192	CcSEcCtD
Levobupivacaine—Dyspnoea—Valproic Acid—epilepsy syndrome	2.71e-05	0.000192	CcSEcCtD
Levobupivacaine—Diarrhoea—Carbamazepine—epilepsy syndrome	2.7e-05	0.000192	CcSEcCtD
Levobupivacaine—Pruritus—Lamotrigine—epilepsy syndrome	2.7e-05	0.000191	CcSEcCtD
Levobupivacaine—Shock—Pregabalin—epilepsy syndrome	2.7e-05	0.000191	CcSEcCtD
Levobupivacaine—Somnolence—Valproic Acid—epilepsy syndrome	2.7e-05	0.000191	CcSEcCtD
Levobupivacaine—Nervous system disorder—Pregabalin—epilepsy syndrome	2.69e-05	0.000191	CcSEcCtD
Levobupivacaine—Cough—Gabapentin—epilepsy syndrome	2.69e-05	0.000191	CcSEcCtD
Levobupivacaine—Tachycardia—Pregabalin—epilepsy syndrome	2.68e-05	0.00019	CcSEcCtD
Levobupivacaine—Chills—Topiramate—epilepsy syndrome	2.67e-05	0.000189	CcSEcCtD
Levobupivacaine—Dyspepsia—Valproic Acid—epilepsy syndrome	2.67e-05	0.000189	CcSEcCtD
Levobupivacaine—Convulsion—Gabapentin—epilepsy syndrome	2.67e-05	0.000189	CcSEcCtD
Levobupivacaine—Skin disorder—Pregabalin—epilepsy syndrome	2.67e-05	0.000189	CcSEcCtD
Levobupivacaine—Hypertension—Gabapentin—epilepsy syndrome	2.66e-05	0.000189	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.65e-05	0.000188	CcSEcCtD
Levobupivacaine—Vomiting—Clonazepam—epilepsy syndrome	2.65e-05	0.000188	CcSEcCtD
Levobupivacaine—Decreased appetite—Valproic Acid—epilepsy syndrome	2.64e-05	0.000187	CcSEcCtD
Levobupivacaine—Vomiting—Phenytoin—epilepsy syndrome	2.63e-05	0.000187	CcSEcCtD
Levobupivacaine—Arthralgia—Gabapentin—epilepsy syndrome	2.62e-05	0.000186	CcSEcCtD
Levobupivacaine—Nausea—Felbamate—epilepsy syndrome	2.62e-05	0.000186	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.62e-05	0.000186	CcSEcCtD
Levobupivacaine—Vomiting—Oxcarbazepine—epilepsy syndrome	2.62e-05	0.000186	CcSEcCtD
Levobupivacaine—Anxiety—Gabapentin—epilepsy syndrome	2.62e-05	0.000185	CcSEcCtD
Levobupivacaine—Dizziness—Carbamazepine—epilepsy syndrome	2.61e-05	0.000185	CcSEcCtD
Levobupivacaine—Diarrhoea—Lamotrigine—epilepsy syndrome	2.61e-05	0.000185	CcSEcCtD
Levobupivacaine—Headache—Clonazepam—epilepsy syndrome	2.61e-05	0.000185	CcSEcCtD
Levobupivacaine—Mental disorder—Topiramate—epilepsy syndrome	2.61e-05	0.000185	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.61e-05	0.000185	CcSEcCtD
Levobupivacaine—Pain—Valproic Acid—epilepsy syndrome	2.6e-05	0.000184	CcSEcCtD
Levobupivacaine—Constipation—Valproic Acid—epilepsy syndrome	2.6e-05	0.000184	CcSEcCtD
Levobupivacaine—Headache—Phenytoin—epilepsy syndrome	2.59e-05	0.000184	CcSEcCtD
Levobupivacaine—Malnutrition—Topiramate—epilepsy syndrome	2.59e-05	0.000184	CcSEcCtD
Levobupivacaine—Erythema—Topiramate—epilepsy syndrome	2.59e-05	0.000184	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—KDR—epilepsy syndrome	2.59e-05	0.000469	CbGpPWpGaD
Levobupivacaine—Headache—Oxcarbazepine—epilepsy syndrome	2.58e-05	0.000183	CcSEcCtD
Levobupivacaine—Nausea—Zonisamide—epilepsy syndrome	2.57e-05	0.000182	CcSEcCtD
Levobupivacaine—Hypotension—Pregabalin—epilepsy syndrome	2.56e-05	0.000182	CcSEcCtD
Levobupivacaine—Flatulence—Topiramate—epilepsy syndrome	2.56e-05	0.000181	CcSEcCtD
Levobupivacaine—Tension—Topiramate—epilepsy syndrome	2.55e-05	0.00018	CcSEcCtD
Levobupivacaine—Confusional state—Gabapentin—epilepsy syndrome	2.54e-05	0.00018	CcSEcCtD
Levobupivacaine—Dizziness—Lamotrigine—epilepsy syndrome	2.53e-05	0.000179	CcSEcCtD
Levobupivacaine—Nervousness—Topiramate—epilepsy syndrome	2.52e-05	0.000178	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.52e-05	0.000178	CcSEcCtD
Levobupivacaine—Oedema—Gabapentin—epilepsy syndrome	2.52e-05	0.000178	CcSEcCtD
Levobupivacaine—Vomiting—Carbamazepine—epilepsy syndrome	2.51e-05	0.000178	CcSEcCtD
Levobupivacaine—Back pain—Topiramate—epilepsy syndrome	2.51e-05	0.000178	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	2.5e-05	0.000454	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	2.5e-05	0.000454	CbGpPWpGaD
Levobupivacaine—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.5e-05	0.000177	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.5e-05	0.000177	CcSEcCtD
Levobupivacaine—Infection—Gabapentin—epilepsy syndrome	2.5e-05	0.000177	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—KDR—epilepsy syndrome	2.5e-05	0.000453	CbGpPWpGaD
Levobupivacaine—Muscle spasms—Topiramate—epilepsy syndrome	2.49e-05	0.000177	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—IL6ST—epilepsy syndrome	2.48e-05	0.00045	CbGpPWpGaD
Levobupivacaine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.48e-05	0.000176	CcSEcCtD
Levobupivacaine—Insomnia—Pregabalin—epilepsy syndrome	2.48e-05	0.000176	CcSEcCtD
Levobupivacaine—Nausea—Clonazepam—epilepsy syndrome	2.48e-05	0.000175	CcSEcCtD
Levobupivacaine—Headache—Carbamazepine—epilepsy syndrome	2.48e-05	0.000175	CcSEcCtD
Levobupivacaine—Shock—Gabapentin—epilepsy syndrome	2.48e-05	0.000175	CcSEcCtD
Levobupivacaine—Nervous system disorder—Gabapentin—epilepsy syndrome	2.47e-05	0.000175	CcSEcCtD
Levobupivacaine—Paraesthesia—Pregabalin—epilepsy syndrome	2.46e-05	0.000175	CcSEcCtD
Levobupivacaine—Nausea—Phenytoin—epilepsy syndrome	2.46e-05	0.000174	CcSEcCtD
Levobupivacaine—Tachycardia—Gabapentin—epilepsy syndrome	2.46e-05	0.000174	CcSEcCtD
Levobupivacaine—Dyspnoea—Pregabalin—epilepsy syndrome	2.45e-05	0.000173	CcSEcCtD
Levobupivacaine—Nausea—Oxcarbazepine—epilepsy syndrome	2.45e-05	0.000173	CcSEcCtD
Levobupivacaine—Vision blurred—Topiramate—epilepsy syndrome	2.44e-05	0.000173	CcSEcCtD
Levobupivacaine—Skin disorder—Gabapentin—epilepsy syndrome	2.44e-05	0.000173	CcSEcCtD
Levobupivacaine—Somnolence—Pregabalin—epilepsy syndrome	2.44e-05	0.000173	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.43e-05	0.000172	CcSEcCtD
Levobupivacaine—Tremor—Topiramate—epilepsy syndrome	2.43e-05	0.000172	CcSEcCtD
Levobupivacaine—Vomiting—Lamotrigine—epilepsy syndrome	2.43e-05	0.000172	CcSEcCtD
Levobupivacaine—Urticaria—Valproic Acid—epilepsy syndrome	2.41e-05	0.000171	CcSEcCtD
Levobupivacaine—Body temperature increased—Valproic Acid—epilepsy syndrome	2.4e-05	0.00017	CcSEcCtD
Levobupivacaine—Abdominal pain—Valproic Acid—epilepsy syndrome	2.4e-05	0.00017	CcSEcCtD
Levobupivacaine—Anaemia—Topiramate—epilepsy syndrome	2.4e-05	0.00017	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—IL6ST—epilepsy syndrome	2.39e-05	0.000434	CbGpPWpGaD
Levobupivacaine—Headache—Lamotrigine—epilepsy syndrome	2.39e-05	0.00017	CcSEcCtD
Levobupivacaine—Decreased appetite—Pregabalin—epilepsy syndrome	2.39e-05	0.000169	CcSEcCtD
Levobupivacaine—Agitation—Topiramate—epilepsy syndrome	2.38e-05	0.000169	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.37e-05	0.000168	CcSEcCtD
Levobupivacaine—Lidocaine—CYP2D6—epilepsy syndrome	2.37e-05	0.00488	CrCbGaD
Levobupivacaine—Hypotension—Gabapentin—epilepsy syndrome	2.35e-05	0.000167	CcSEcCtD
Levobupivacaine—Nausea—Carbamazepine—epilepsy syndrome	2.35e-05	0.000166	CcSEcCtD
Levobupivacaine—Pain—Pregabalin—epilepsy syndrome	2.35e-05	0.000166	CcSEcCtD
Levobupivacaine—Constipation—Pregabalin—epilepsy syndrome	2.35e-05	0.000166	CcSEcCtD
Levobupivacaine—Syncope—Topiramate—epilepsy syndrome	2.33e-05	0.000165	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.29e-05	0.000162	CcSEcCtD
Levobupivacaine—Palpitations—Topiramate—epilepsy syndrome	2.29e-05	0.000162	CcSEcCtD
Levobupivacaine—Tocainide—ALB—epilepsy syndrome	2.29e-05	0.00473	CrCbGaD
Levobupivacaine—Loss of consciousness—Topiramate—epilepsy syndrome	2.28e-05	0.000162	CcSEcCtD
Levobupivacaine—Insomnia—Gabapentin—epilepsy syndrome	2.28e-05	0.000161	CcSEcCtD
Levobupivacaine—Nausea—Lamotrigine—epilepsy syndrome	2.27e-05	0.000161	CcSEcCtD
Levobupivacaine—Cough—Topiramate—epilepsy syndrome	2.26e-05	0.00016	CcSEcCtD
Levobupivacaine—Feeling abnormal—Pregabalin—epilepsy syndrome	2.26e-05	0.00016	CcSEcCtD
Levobupivacaine—Paraesthesia—Gabapentin—epilepsy syndrome	2.26e-05	0.00016	CcSEcCtD
Levobupivacaine—Convulsion—Topiramate—epilepsy syndrome	2.25e-05	0.000159	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.24e-05	0.000159	CcSEcCtD
Levobupivacaine—Dyspnoea—Gabapentin—epilepsy syndrome	2.24e-05	0.000159	CcSEcCtD
Levobupivacaine—Hypertension—Topiramate—epilepsy syndrome	2.24e-05	0.000159	CcSEcCtD
Levobupivacaine—Somnolence—Gabapentin—epilepsy syndrome	2.24e-05	0.000158	CcSEcCtD
Levobupivacaine—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.24e-05	0.000158	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	2.23e-05	0.000404	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—MMP9—epilepsy syndrome	2.23e-05	0.000404	CbGpPWpGaD
Levobupivacaine—Dyspepsia—Gabapentin—epilepsy syndrome	2.21e-05	0.000157	CcSEcCtD
Levobupivacaine—Arthralgia—Topiramate—epilepsy syndrome	2.21e-05	0.000156	CcSEcCtD
Levobupivacaine—Anxiety—Topiramate—epilepsy syndrome	2.2e-05	0.000156	CcSEcCtD
Levobupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.19e-05	0.000398	CbGpPWpGaD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.19e-05	0.000155	CcSEcCtD
Levobupivacaine—Decreased appetite—Gabapentin—epilepsy syndrome	2.19e-05	0.000155	CcSEcCtD
Levobupivacaine—Urticaria—Pregabalin—epilepsy syndrome	2.18e-05	0.000154	CcSEcCtD
Levobupivacaine—Asthenia—Valproic Acid—epilepsy syndrome	2.18e-05	0.000154	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.17e-05	0.000154	CcSEcCtD
Levobupivacaine—Body temperature increased—Pregabalin—epilepsy syndrome	2.17e-05	0.000154	CcSEcCtD
Levobupivacaine—Abdominal pain—Pregabalin—epilepsy syndrome	2.17e-05	0.000154	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—epilepsy syndrome	2.16e-05	0.000392	CbGpPWpGaD
Levobupivacaine—Pain—Gabapentin—epilepsy syndrome	2.15e-05	0.000152	CcSEcCtD
Levobupivacaine—Constipation—Gabapentin—epilepsy syndrome	2.15e-05	0.000152	CcSEcCtD
Levobupivacaine—CYP1A2—Biological oxidations—CYP2C19—epilepsy syndrome	2.15e-05	0.00039	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—MMP9—epilepsy syndrome	2.15e-05	0.000389	CbGpPWpGaD
Levobupivacaine—Pruritus—Valproic Acid—epilepsy syndrome	2.15e-05	0.000152	CcSEcCtD
Levobupivacaine—CYP1A2—Biological oxidations—CYP11A1—epilepsy syndrome	2.14e-05	0.000387	CbGpPWpGaD
Levobupivacaine—Confusional state—Topiramate—epilepsy syndrome	2.13e-05	0.000151	CcSEcCtD
Levobupivacaine—CYP1A2—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.12e-05	0.000384	CbGpPWpGaD
Levobupivacaine—Oedema—Topiramate—epilepsy syndrome	2.12e-05	0.00015	CcSEcCtD
Levobupivacaine—CYP1A2—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.11e-05	0.000382	CbGpPWpGaD
Levobupivacaine—Infection—Topiramate—epilepsy syndrome	2.1e-05	0.000149	CcSEcCtD
Levobupivacaine—Shock—Topiramate—epilepsy syndrome	2.08e-05	0.000148	CcSEcCtD
Levobupivacaine—Diarrhoea—Valproic Acid—epilepsy syndrome	2.08e-05	0.000147	CcSEcCtD
Levobupivacaine—Nervous system disorder—Topiramate—epilepsy syndrome	2.08e-05	0.000147	CcSEcCtD
Levobupivacaine—Feeling abnormal—Gabapentin—epilepsy syndrome	2.07e-05	0.000147	CcSEcCtD
Levobupivacaine—Tachycardia—Topiramate—epilepsy syndrome	2.07e-05	0.000146	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.06e-05	0.000146	CcSEcCtD
Levobupivacaine—Skin disorder—Topiramate—epilepsy syndrome	2.06e-05	0.000146	CcSEcCtD
Levobupivacaine—SCN4A—Axon guidance—SRC—epilepsy syndrome	2.05e-05	0.000372	CbGpPWpGaD
Levobupivacaine—Hyperhidrosis—Topiramate—epilepsy syndrome	2.05e-05	0.000145	CcSEcCtD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	2.02e-05	0.000367	CbGpPWpGaD
Levobupivacaine—Hypersensitivity—Pregabalin—epilepsy syndrome	2.02e-05	0.000143	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	2.01e-05	0.000365	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—FGF2—epilepsy syndrome	2.01e-05	0.000364	CbGpPWpGaD
Levobupivacaine—Dizziness—Valproic Acid—epilepsy syndrome	2.01e-05	0.000142	CcSEcCtD
Levobupivacaine—SCN4A—Axon guidance—VEGFA—epilepsy syndrome	2e-05	0.000362	CbGpPWpGaD
Levobupivacaine—Urticaria—Gabapentin—epilepsy syndrome	2e-05	0.000142	CcSEcCtD
Levobupivacaine—Abdominal pain—Gabapentin—epilepsy syndrome	1.99e-05	0.000141	CcSEcCtD
Levobupivacaine—Body temperature increased—Gabapentin—epilepsy syndrome	1.99e-05	0.000141	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—SRC—epilepsy syndrome	1.98e-05	0.000359	CbGpPWpGaD
Levobupivacaine—Hypotension—Topiramate—epilepsy syndrome	1.98e-05	0.00014	CcSEcCtD
Levobupivacaine—Asthenia—Pregabalin—epilepsy syndrome	1.97e-05	0.000139	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	1.95e-05	0.000354	CbGpPWpGaD
Levobupivacaine—Pruritus—Pregabalin—epilepsy syndrome	1.94e-05	0.000138	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—FGF2—epilepsy syndrome	1.94e-05	0.000351	CbGpPWpGaD
Levobupivacaine—Vomiting—Valproic Acid—epilepsy syndrome	1.93e-05	0.000137	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.93e-05	0.000137	CcSEcCtD
Levobupivacaine—CYP1A2—Biological oxidations—CYP2D6—epilepsy syndrome	1.93e-05	0.000349	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—VEGFA—epilepsy syndrome	1.93e-05	0.000349	CbGpPWpGaD
Levobupivacaine—Insomnia—Topiramate—epilepsy syndrome	1.91e-05	0.000136	CcSEcCtD
Levobupivacaine—SCN10A—ganglion—epilepsy syndrome	1.9e-05	0.244	CbGeAlD
Levobupivacaine—CYP1A2—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.9e-05	0.000345	CbGpPWpGaD
Levobupivacaine—Headache—Valproic Acid—epilepsy syndrome	1.9e-05	0.000135	CcSEcCtD
Levobupivacaine—Paraesthesia—Topiramate—epilepsy syndrome	1.9e-05	0.000135	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	1.9e-05	0.000344	CbGpPWpGaD
Levobupivacaine—Dyspnoea—Topiramate—epilepsy syndrome	1.89e-05	0.000134	CcSEcCtD
Levobupivacaine—Somnolence—Topiramate—epilepsy syndrome	1.88e-05	0.000133	CcSEcCtD
Levobupivacaine—Diarrhoea—Pregabalin—epilepsy syndrome	1.88e-05	0.000133	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—RELA—epilepsy syndrome	1.86e-05	0.000338	CbGpPWpGaD
Levobupivacaine—Dyspepsia—Topiramate—epilepsy syndrome	1.86e-05	0.000132	CcSEcCtD
Levobupivacaine—Hypersensitivity—Gabapentin—epilepsy syndrome	1.85e-05	0.000131	CcSEcCtD
Levobupivacaine—Decreased appetite—Topiramate—epilepsy syndrome	1.84e-05	0.00013	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.83e-05	0.000129	CcSEcCtD
Levobupivacaine—Dizziness—Pregabalin—epilepsy syndrome	1.81e-05	0.000129	CcSEcCtD
Levobupivacaine—Pain—Topiramate—epilepsy syndrome	1.81e-05	0.000128	CcSEcCtD
Levobupivacaine—Constipation—Topiramate—epilepsy syndrome	1.81e-05	0.000128	CcSEcCtD
Levobupivacaine—Asthenia—Gabapentin—epilepsy syndrome	1.81e-05	0.000128	CcSEcCtD
Levobupivacaine—Nausea—Valproic Acid—epilepsy syndrome	1.8e-05	0.000128	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—RELA—epilepsy syndrome	1.8e-05	0.000326	CbGpPWpGaD
Levobupivacaine—Pruritus—Gabapentin—epilepsy syndrome	1.78e-05	0.000126	CcSEcCtD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.78e-05	0.000322	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	1.75e-05	0.000317	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	1.75e-05	0.000317	CbGpPWpGaD
Levobupivacaine—Vomiting—Pregabalin—epilepsy syndrome	1.74e-05	0.000124	CcSEcCtD
Levobupivacaine—Feeling abnormal—Topiramate—epilepsy syndrome	1.74e-05	0.000124	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	1.73e-05	0.000314	CbGpPWpGaD
Levobupivacaine—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.73e-05	0.000123	CcSEcCtD
Levobupivacaine—Diarrhoea—Gabapentin—epilepsy syndrome	1.72e-05	0.000122	CcSEcCtD
Levobupivacaine—Headache—Pregabalin—epilepsy syndrome	1.72e-05	0.000122	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	1.7e-05	0.000309	CbGpPWpGaD
Levobupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.69e-05	0.000307	CbGpPWpGaD
Levobupivacaine—Lidocaine—ABCB1—epilepsy syndrome	1.69e-05	0.00349	CrCbGaD
Levobupivacaine—Urticaria—Topiramate—epilepsy syndrome	1.68e-05	0.000119	CcSEcCtD
Levobupivacaine—Body temperature increased—Topiramate—epilepsy syndrome	1.67e-05	0.000119	CcSEcCtD
Levobupivacaine—Abdominal pain—Topiramate—epilepsy syndrome	1.67e-05	0.000119	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	1.67e-05	0.000303	CbGpPWpGaD
Levobupivacaine—Dizziness—Gabapentin—epilepsy syndrome	1.66e-05	0.000118	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	1.66e-05	0.000301	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	1.65e-05	0.000299	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.64e-05	0.000297	CbGpPWpGaD
Levobupivacaine—Nausea—Pregabalin—epilepsy syndrome	1.63e-05	0.000115	CcSEcCtD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.63e-05	0.000295	CbGpPWpGaD
Levobupivacaine—Vomiting—Gabapentin—epilepsy syndrome	1.6e-05	0.000113	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—MMP9—epilepsy syndrome	1.59e-05	0.000288	CbGpPWpGaD
Levobupivacaine—Headache—Gabapentin—epilepsy syndrome	1.58e-05	0.000112	CcSEcCtD
Levobupivacaine—Hypersensitivity—Topiramate—epilepsy syndrome	1.56e-05	0.00011	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—MMP9—epilepsy syndrome	1.53e-05	0.000278	CbGpPWpGaD
Levobupivacaine—Asthenia—Topiramate—epilepsy syndrome	1.52e-05	0.000108	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	1.52e-05	0.000275	CbGpPWpGaD
Levobupivacaine—Pruritus—Topiramate—epilepsy syndrome	1.5e-05	0.000106	CcSEcCtD
Levobupivacaine—Nausea—Gabapentin—epilepsy syndrome	1.49e-05	0.000106	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.49e-05	0.00027	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CA13—epilepsy syndrome	1.47e-05	0.000267	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.47e-05	0.000266	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—SRC—epilepsy syndrome	1.47e-05	0.000266	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	1.46e-05	0.000265	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	1.46e-05	0.000265	CbGpPWpGaD
Levobupivacaine—Diarrhoea—Topiramate—epilepsy syndrome	1.45e-05	0.000103	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—VEGFA—epilepsy syndrome	1.43e-05	0.000259	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—SRC—epilepsy syndrome	1.41e-05	0.000256	CbGpPWpGaD
Levobupivacaine—Dizziness—Topiramate—epilepsy syndrome	1.4e-05	9.92e-05	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—VEGFA—epilepsy syndrome	1.38e-05	0.000249	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.37e-05	0.000249	CbGpPWpGaD
Levobupivacaine—Vomiting—Topiramate—epilepsy syndrome	1.35e-05	9.54e-05	CcSEcCtD
Levobupivacaine—Headache—Topiramate—epilepsy syndrome	1.33e-05	9.4e-05	CcSEcCtD
Levobupivacaine—Nausea—Topiramate—epilepsy syndrome	1.26e-05	8.91e-05	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—TNF—epilepsy syndrome	1.22e-05	0.000222	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.18e-05	0.000215	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—TNF—epilepsy syndrome	1.18e-05	0.000214	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.14e-05	0.000206	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	1.11e-05	0.000202	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CERS1—epilepsy syndrome	1.11e-05	0.000202	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	1.11e-05	0.000202	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—FAR1—epilepsy syndrome	1.11e-05	0.000202	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ADK—epilepsy syndrome	1.11e-05	0.000202	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PDXK—epilepsy syndrome	1.11e-05	0.000202	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	1.02e-05	0.000185	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PNPO—epilepsy syndrome	1.02e-05	0.000185	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	1.02e-05	0.000185	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GAMT—epilepsy syndrome	1.02e-05	0.000185	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—QDPR—epilepsy syndrome	9.48e-06	0.000172	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CA4—epilepsy syndrome	9.48e-06	0.000172	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	9.45e-06	0.000171	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—AKT1—epilepsy syndrome	9.11e-06	0.000165	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—COX3—epilepsy syndrome	8.91e-06	0.000161	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—AKT1—epilepsy syndrome	8.78e-06	0.000159	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ADK—epilepsy syndrome	8.6e-06	0.000156	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PDXK—epilepsy syndrome	8.6e-06	0.000156	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	8.6e-06	0.000156	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—FAR1—epilepsy syndrome	8.6e-06	0.000156	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CERS1—epilepsy syndrome	8.6e-06	0.000156	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	8.6e-06	0.000156	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	8.45e-06	0.000153	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	8.45e-06	0.000153	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PFKL—epilepsy syndrome	8.45e-06	0.000153	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	8.45e-06	0.000153	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	8.45e-06	0.000153	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	8.26e-06	0.00015	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	8.2e-06	0.000149	CbGpPWpGaD
Levobupivacaine—SCN10A—forebrain—epilepsy syndrome	7.98e-06	0.102	CbGeAlD
Levobupivacaine—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	7.87e-06	0.000143	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GAMT—epilepsy syndrome	7.87e-06	0.000143	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	7.87e-06	0.000143	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PNPO—epilepsy syndrome	7.87e-06	0.000143	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ATIC—epilepsy syndrome	7.73e-06	0.00014	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—UPB1—epilepsy syndrome	7.73e-06	0.00014	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NEU1—epilepsy syndrome	7.73e-06	0.00014	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	7.44e-06	0.000135	CbGpPWpGaD
Levobupivacaine—SCN10A—telencephalon—epilepsy syndrome	7.34e-06	0.094	CbGeAlD
Levobupivacaine—CYP3A4—Metabolism—CA4—epilepsy syndrome	7.31e-06	0.000133	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—QDPR—epilepsy syndrome	7.31e-06	0.000133	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	7.29e-06	0.000132	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	7.18e-06	0.00013	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GBE1—epilepsy syndrome	7.18e-06	0.00013	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	7.02e-06	0.000127	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.88e-06	0.000125	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	6.75e-06	0.000122	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	6.57e-06	0.000119	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.52e-06	0.000118	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.52e-06	0.000118	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.52e-06	0.000118	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.52e-06	0.000118	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.52e-06	0.000118	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NT5E—epilepsy syndrome	6.4e-06	0.000116	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALAD—epilepsy syndrome	6.4e-06	0.000116	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	6.11e-06	0.000111	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	6.11e-06	0.000111	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	5.98e-06	0.000108	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.96e-06	0.000108	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.96e-06	0.000108	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.96e-06	0.000108	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ADSL—epilepsy syndrome	5.86e-06	0.000106	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GLUL—epilepsy syndrome	5.74e-06	0.000104	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.74e-06	0.000104	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	5.64e-06	0.000102	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.54e-06	0.0001	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.54e-06	0.0001	CbGpPWpGaD
Levobupivacaine—SCN4A—head—epilepsy syndrome	5.36e-06	0.0686	CbGeAlD
Levobupivacaine—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	5.27e-06	9.55e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.21e-06	9.44e-05	CbGpPWpGaD
Levobupivacaine—SCN10A—spinal cord—epilepsy syndrome	5.14e-06	0.0659	CbGeAlD
Levobupivacaine—CYP1A2—Metabolism—AQP1—epilepsy syndrome	5.12e-06	9.27e-05	CbGpPWpGaD
Levobupivacaine—SCN4A—nervous system—epilepsy syndrome	5.08e-06	0.0651	CbGeAlD
Levobupivacaine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.07e-06	9.19e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.94e-06	8.95e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.94e-06	8.95e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.92e-06	8.91e-05	CbGpPWpGaD
Levobupivacaine—SCN4A—central nervous system—epilepsy syndrome	4.89e-06	0.0626	CbGeAlD
Levobupivacaine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.71e-06	8.54e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.71e-06	8.54e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	4.63e-06	8.39e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	4.63e-06	8.39e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.61e-06	8.36e-05	CbGpPWpGaD
Levobupivacaine—SCN10A—head—epilepsy syndrome	4.57e-06	0.0586	CbGeAlD
Levobupivacaine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.52e-06	8.19e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.43e-06	8.03e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.35e-06	7.88e-05	CbGpPWpGaD
Levobupivacaine—SCN10A—nervous system—epilepsy syndrome	4.33e-06	0.0555	CbGeAlD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.31e-06	7.81e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.22e-06	7.65e-05	CbGpPWpGaD
Levobupivacaine—SCN10A—central nervous system—epilepsy syndrome	4.17e-06	0.0535	CbGeAlD
Levobupivacaine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.07e-06	7.37e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.95e-06	7.16e-05	CbGpPWpGaD
Levobupivacaine—SCN4A—brain—epilepsy syndrome	3.88e-06	0.0497	CbGeAlD
Levobupivacaine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	3.77e-06	6.84e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	3.68e-06	6.66e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	3.65e-06	6.62e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.63e-06	6.57e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.57e-06	6.47e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.57e-06	6.47e-05	CbGpPWpGaD
Levobupivacaine—SCN10A—brain—epilepsy syndrome	3.31e-06	0.0424	CbGeAlD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.31e-06	5.99e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	3.3e-06	5.98e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	3.14e-06	5.69e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	3.13e-06	5.67e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.98e-06	5.4e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.95e-06	5.35e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TH—epilepsy syndrome	2.94e-06	5.33e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.91e-06	5.28e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.89e-06	5.24e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.84e-06	5.14e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.82e-06	5.11e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.55e-06	4.61e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	2.45e-06	4.45e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.42e-06	4.39e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CAT—epilepsy syndrome	2.42e-06	4.39e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.41e-06	4.37e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	2.35e-06	4.27e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.3e-06	4.17e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.28e-06	4.13e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TH—epilepsy syndrome	2.27e-06	4.11e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.19e-06	3.97e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.92e-06	3.48e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.89e-06	3.43e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.88e-06	3.41e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.87e-06	3.39e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.82e-06	3.29e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.69e-06	3.06e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.62e-06	2.93e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—nervous system—epilepsy syndrome	1.5e-06	0.0192	CbGeAlD
Levobupivacaine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.48e-06	2.68e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.47e-06	2.67e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.45e-06	2.63e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—central nervous system—epilepsy syndrome	1.44e-06	0.0185	CbGeAlD
Levobupivacaine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.29e-06	2.34e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.25e-06	2.26e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.14e-06	2.06e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.95e-07	1.8e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	6.48e-07	1.17e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5e-07	9.06e-06	CbGpPWpGaD
